Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
- PMID: 38202328
- PMCID: PMC10780634
- DOI: 10.3390/plants13010020
Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
Abstract
Moringa oleifera (M. oleifera) is a tropical tree native to Pakistan, India, Bangladesh, and Afghanistan; it is cultivated for its nutritious leaves, pods, and seeds. This scientific study was conducted to outline the anti-inflammatory properties and mechanisms of action of bioactive compounds from M. oleifera. The existing research has found that the plant is used in traditional medicine due to its bioactive compounds, including phytochemicals: flavonoids and polyphenols. The compounds are thought to exert their anti-inflammatory effects due to: (1) inhibition of pro-inflammatory enzymes: quercetin and kaempferol inhibit the pro-inflammatory enzymes (cyclooxygenase and lipoxygenase); (2) regulation of cytokine production: isothiocyanates modulate signaling pathways involved in inflammation, such as the nuclear factor-kappa B (NF-kappa B) pathway; isothiocyanates inhibit the production of pro-inflammatory cytokines such as TNF-α (tumor necrosis factor α) and IL-1β (interleukin-1β); and (3) antioxidant activity: M. oleifera contains flavonoids, polyphenols, known to reduce oxidative stress and inflammation. The review includes M. oleifera's effects on cardiovascular protection, anti-hypertensive activities, type 2 diabetes, inflammatory bowel disease, and non-alcoholic fatty liver disease (NAFLD). This research could prove valuable for exploring the pharmacological potential of M. oleifera and contributing to the prospects of developing effective medicines for the benefit of human health.
Keywords: Moringa oleifera; NAFLD; anti-inflammatory activity; anti-oxidative stress; chronic inflammatory diseases; kaempferol; nuclear factor-kappa B; polyphenols; quercetin; type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Bioactive Extract from Moringa oleifera Inhibits the Pro-inflammatory Mediators in Lipopolysaccharide Stimulated Macrophages.Pharmacogn Mag. 2015 Oct;11(Suppl 4):S556-63. doi: 10.4103/0973-1296.172961. Pharmacogn Mag. 2015. PMID: 27013794 Free PMC article.
-
Bioactive components and anti-diabetic properties of Moringa oleifera Lam.Crit Rev Food Sci Nutr. 2022;62(14):3873-3897. doi: 10.1080/10408398.2020.1870099. Epub 2021 Jan 6. Crit Rev Food Sci Nutr. 2022. PMID: 33401950 Review.
-
Aqueous M. oleifera leaf extract alleviates DSS-induced colitis in mice through suppression of inflammation.J Ethnopharmacol. 2024 Jan 10;318(Pt B):116929. doi: 10.1016/j.jep.2023.116929. Epub 2023 Jul 20. J Ethnopharmacol. 2024. PMID: 37480965
-
Neuroprotective potential of Moringa oleifera mediated by NF-kB/Nrf2/HO-1 signaling pathway: A review.J Food Biochem. 2022 Dec;46(12):e14451. doi: 10.1111/jfbc.14451. Epub 2022 Oct 7. J Food Biochem. 2022. PMID: 36206551 Review.
-
Phytochemical Analysis, Antimutagenic and Antiviral Activity of Moringa oleifera L. Leaf Infusion: In Vitro and In Silico Studies.Molecules. 2022 Jun 22;27(13):4017. doi: 10.3390/molecules27134017. Molecules. 2022. PMID: 35807260 Free PMC article.
Cited by
-
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.Pharmaceuticals (Basel). 2024 Oct 10;17(10):1354. doi: 10.3390/ph17101354. Pharmaceuticals (Basel). 2024. PMID: 39458995 Free PMC article. Review.
-
Electrophoretic deposition of polyvinyl alcohol, C-H NRs along with moringa on an SS substrate for orthopedic implant applications.RSC Adv. 2024 Aug 23;14(37):26775-26787. doi: 10.1039/d4ra03931a. eCollection 2024 Aug 22. RSC Adv. 2024. PMID: 39184003 Free PMC article.
-
Effects of Moringa oleifera Leaf Powder on the Growth Performance, Meat Quality, Blood Parameters, and Cecal Bacteria of Broilers.Vet Sci. 2024 Aug 14;11(8):374. doi: 10.3390/vetsci11080374. Vet Sci. 2024. PMID: 39195828 Free PMC article.
-
Effect of moringa seed extract in chlorpyrifos-induced cerebral and ocular toxicity in mice.Front Vet Sci. 2024 Apr 10;11:1381428. doi: 10.3389/fvets.2024.1381428. eCollection 2024. Front Vet Sci. 2024. PMID: 38659447 Free PMC article.
-
Unveiling the Miracle Tree: Therapeutic Potential of Moringa oleifera in Chronic Disease Management and Beyond.Biomedicines. 2025 Mar 5;13(3):634. doi: 10.3390/biomedicines13030634. Biomedicines. 2025. PMID: 40149610 Free PMC article. Review.
References
-
- Ezzat S.M., Jeevanandam J., Egbuna C., Kumar S., Ifemeje J.C. Phytochemicals as Sources of Drugs. In: Kumar S., Egbuna C., editors. Phytochemistry: An In-Silico and In-Vitro Update. Springer; Singapore: 2019. pp. 3–22.
-
- Kuete V. Moringa oleifera. In: Kuete V., editor. Medicinal Spices and Vegetables from Africa. Elsevier; Amsterdam, The Netherlands: 2017. pp. 485–496.
-
- Noubissi P.A., Njilifac Q., Tagne M.A.F., Nguepi M.S.D., Fondjo A.F., Emégam N.K., Mukam J.N., Zintchem R., Wambe H., Fankem G.O., et al. Anxiolytic and anti-colitis effects of Moringa oleifera leaf-aqueous extract on acetic acid-induced colon inflammation in rat. Biomed. Pharmacother. 2022;154:113652. doi: 10.1016/j.biopha.2022.113652. - DOI - PubMed
-
- Foidl N., Makkar H., Becker K. The Potential of Moringa oleifera for agricultural and industrial uses. In: Fuglie L.J., editor. The Miracle Tree: The Multiple Attributes of Moringa. CTA; Wageningen, The Netherlands: CWS; Dakar, Senegal: 2001. pp. 45–76.
Publication types
LinkOut - more resources
Full Text Sources